Skip to main content
Premium Trial:

Request an Annual Quote

France Invests in Sequencing Centers

France is to invest some €670 million in personalized medicine, RFI reports. In particular, those fund are to go toward the establishment of a dozen genome sequencing centers to help treat cancer, diabetes, and rare diseases, it adds.

This move comes in response to a report recently submitted by medical experts to Prime Minister Manuel Valls, according to French Health Minister Marisol Touraine. Sequencing, RFI adds, will enable clinicians to make more precise diagnoses and avoid unnecessary tests. For instance, sequencing tumors, it says, can better guide treatment decisions as well as enable the testing of new therapies.

"Genome-related medicine should also extend specialists' knowledge of common complaints like diabetes and allow patients suffering from rare diseases to find suitable treatment more quickly," it adds.

Touraine adds that some of the funds will come from companies. RFI notes that firms like Google, Apple, and Facebook are all interested in the field.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.